Malignant hematopoietic cell lines: In vitro models for the study of myelodysplastic syndromes

Leukemia Research

Volumn 24, Issue 2, 2000, Pages 109-115

  Drexler, Hans G ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

AML; Cell lines; Leukemia; MDS

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; MODEL; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0034142672     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)90169-8     Document Type: Short Survey

References (61)

1. Heaney M.L., Golde D.W. Myelodysplasia. New Engl. J. Med. 340:1999;1649.
2. Beris P. Primary clonal myelodysplastic syndromes. Semin. Hematol. 26:1989;216.
3. Koeffler H.P. Myelodysplastic syndromes (preleukemia). Semin. Hematol. 23:1986;284.
4. Aul C., Gattermann N., Schneider W. Epidemiological and etiological aspects of myelodysplastic syndromes. Leuk. Lymph. 16:1995;247.
5. Aul C., Germing U., Gattermann N., Minning H. Increasing incidence of myelodysplastic syndromes: real or fictitious. Leuk. Res. 22:1998;93.
6. Hasle H. Myelodysplastic syndromes in childhood - classification, epidemiology, and treatment. Leuk. Lymph. 13:1994;11.
7. Luna-Fineman S., Shannon K.M., Lange B.J. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Leuk. Lymph. 85:1995;1985.
8. Arico M., Biondi A., Pui C.H. Juvenile myelomonocytic leukemia. Blood. 90:1997;479.
9. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. FAB co-operative group proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51:1982;189.
10. Michaux J.L., Martiat P. Chronic myelomonocytic leukaemia (CMML) - A myelodysplastic or myeloproliferative syndrome? Leuk. Lymph. 9:1993;35.
11. Third MIC Cooperative Study Group. Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genet Cytogenet 1988;32:1.
12. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G., Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079.
13. Greenberg P.L. Apoptosis and its role in the myelodysplastic syndromes: Implications for disease natural history and treatment. Leuk. Res. 22:1998;1123.
14. Raza A., Mundle S., Shetty V., Alvi S., Chopra H., Span L., Parcharidou A., Dar S., Venugopal P., Borok R., Gezer S., Showel J., Loew J., Robin E., Rifkin S., Alston D., Hernandez B., Shah R., Kaizer H., Gregory S., Preisler H. A paradigm shift in myelodysplastic syndromes. Leukemia. 10:1996;1648.
15. Ohyashiki K., Ohyashiki J.H., Iwabuchi A., Toyama K. Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes. Leuk. Lymph. 23:1996;409.
16. Mecucci C. Molecular features of primary MDS with cytogenetic changes. Leuk. Res. 22:1998;293.
17. Boultwood J., Lewis S., Wainscoat J.S. The 5q- syndrome. Blood. 84:1994;3253.
18. Castro P.D., Fairman J., Nagarajan L. The unexplored 5q13 locus: a role in hematopoietic malignancies. Leuk. Lymph. 30:1998;443.
19. Nagarajan L. Molecular analysis of the 5q- chromosome. Leuk. Lymph. 17:1995;361.
20. Bartram C.R. Molecular genetic aspects of myelodysplastic syndromes. Hematol. Oncol. Clin. North. Am. 6:1992;557.
21. Sawyer C.L. Molecular abnormalities in myeloid leukemias and myelodysplastic syndromes. Leuk. Res. 22:1998;1113.
22. Drexler H.G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 12:1998;845.
23. Drexler H.G. Leukemia cell lines: In vitro models for the study of chronic myeloid leukemia. Leuk. Res. 18:1994;919.
24. Drexler H.G., Quentmeier H., MacLeod R.A.F., Uphoff C.C., Hu Z.B. Leukemia cell lines: In vitro models for the study of acute promyelocytic leukemia. Leuk. Res. 19:1995;681.
25. Drexler H.G., Uphoff C.C., Gaidano G., Carbone A. Lymphoma cell lines: In vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia. 12:1998;1507.
26. Drexler H.G., MacLeod R.A.F., Uphoff C.C. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Leuk. Res. 23:1999;207.
27. Takiguchi T., Sakuma M., Kim C., Ogawa Y., Takeshita S., Masaki Y., Fukutoku M., Hirose Y., Sugai S. In vitro differentiation of 2 myeloid leukemia cell lines and the effect of anti-proliferative activity by TGF-β Br. J. Haematol. 102:1998;24.
28. Minegishi N., Minegishi M., Tsuchiya S., Fujie H., Nagai T., Hayashi N., Yamamoto M., Konno T. Erythropoietin-dependent induction of hemoglobin synthesis in a cytokine-dependent cell line M-TAT. J. Biol. Chem. 269:1994;27700.
29. Banerjee R., Bekesi J.G., Tarcsafalvi A., Sperber K., Deak G., Choi H.S.H., Paronetto F., Holland J.F., Acs G. Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line. Proc. Natl. Acad. Sci. USA. 89:1992;9996.
30. Tohyama K., Tsutani H., Ueda T., Nakamura T., Yoshida Y. Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome. Br. J. Haematol. 87:1994;235.
31. Tohyama K., Tohyama Y., Nakayama T., Ueda T., Nakamura T., Yoshida Y. A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages. Br. J. Haematol. 91:1995;795.
32. Asimakopoulos F.A., White N.J., Nacheva E., Green A.R. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood. 84:1994;3086.
33. Mizobuchi N., Takahashi I., Horimi T., Yamamoto M., Hamada K., Yorimitsu S., Kubonishi I. Establishment of a new myeloid cell line with i(17q) as the sole chromosomal anomaly from the bone marrow of a patient with myelodysplastic syndrome. Acta. Medica. Okayama. 51:1997;227.
34. Bergamaschi G., Carlo Stella C., Cattoretti G., Invernizzi R., Maserati E., Nalli G., Edrazzoli P., Peverali F.A., Della Valle G., Ascari E., Cazzola M. Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. Br. J. Haematol. 78:1991;167.
35. McCarty T.M., Rajaraman S., Elder F.F.B., Gadson P., Thompson E.B. Establishment and characterization of a human myeloid cell line from Philadelphia chromosome-negative myeloblastic leukemia arising in a patient with myelodysplastic syndrome. Blood. 70:1987;1665.
36. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC, editors. DSMZ Catalogue of Human and Animal Cell Lines, 7th Edition. Braunschweig, Germany: 1999.
37. Freedman M.H., Grunberger T., Correa P., Axelrad A.A., Dube I.D., Cohen A. Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lymphoblastic leukemia cells. Blood. 81:1993;3068.
38. Lau R.C., Squire J., Brisson L., Kamel-Reid S., Grunberger T., Dubé I., Letarte M., Shannon K., Freedman M.H. Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML). Leukemia. 8:1994;903.
39. Attias D., Grunberger T., Vanek W., Estrov Z., Cohen A., Lau R., Freedman M.H. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia. II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts. Leukemia. 9:1995;884.
40. Yamaguchi Y., Nishio H., Kasahara T., Ackerman S.J., Koyanagi J., Suda T. Models of lineage switching in hematopoietic development: A new myeloid-committed eosinophil cell line (YJ) demonstrates trilineage potential. Leukemia. 12:1998;1430.
41. Giavazzi R., Di Berardino C., Garofalo A., Motta T., Gobbi A., Scanziani E., Giudici G., Galli M., Mayo J.G., Barbui T., Biondi A., Rambaldi A. Establishment of human acute myelogenous leukemia lines secreting interleukin-1β in SCID mice. Int. J. Cancer. 61:1995;280.
42. Chiba S., Takaku F., Tange T., Shibuya K., Misawa C., Sasaki K., Miyagawa K., Yazaki Y., Hirai H. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: A parental line requiring granulocyte-macrophage colony- stimulating factor or interleukin-3, and a subline requiring erythropoietin. Blood. 78:1991;2261.
43. Drexler H.G., Zaborski M., Quentmeier H. Cytokine response profiles of human myeloid factor-dependent leukemia cell lines. Leukemia. 11:1997;701.
44. Hamaguchi H., Nagata K., Yamamoto K., Fujikawa I., Kobayashi M., Eguchi M. Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9(p23;q34) and the expression of dek-can chimaeric transcript. Br. J. Haematol. 102:1998;1249.
45. Hamaguchi H., Suzukawa K., Nagata K., Yamamoto K., Yagasaki F., Morishita K. Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, p210 and p190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome. Br. J. Haematol. 98:1997;399.
46. Matsuda M., Maeda Y., Sumimoto Y., Nawata H., Sano T., Higashishiba M., Haga H., Tatsumi Y., Horiuchi F., Irimajiri K., Kanamaru A. Establishment of a myelodysplastic syndrome (MDS)/secondary AML-derived T lymphoid cell line K2-MDS. Leuk. Res. 24:2000;103-108.
47. Nishimaki J, Miyazawa K, Yaguchi M, Katagiri T, Kawanishi Y, Toyama K, Ohyashiki K, Hashimoto S, Nakaya K, Takiguchi T. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome. Leukemia 1999 (in press).
48. Matsuo Y., MacLeod R.A.F., Uphoff C.C., Drexler H.G., Nishizaki C., Katayama Y., Kimura G., Fujii N., Omoto E., Harada M., Orita K. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). Leukemia. 11:1997;1469.
49. Steube K.G., Gignac S.M., Hu Z.B., Teepe D., Harms D., Kabisch H., Gaedicke G., Hansen-Hagge T., MacLeod R.A.F., Quentmeier H., Drexler H.G. In vitro culture studies of childhood myelodysplastic syndrome: Establishment of the cell line MUTZ-1. Leuk. Lymph. 25:1998;345.
50. Tohda S., Yang G.S., Ashman L.K., McCulloch E.A., Minden M.D. Relationship between c-KIT expression and proliferation in acute myeloblastic leukemia cell lines. J. Cell. Physiol. 154:1993;410.
51. Papayannopoulou T., Nakamoto B., Kurachi S., Tweeddale M., Messner H. Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood. 72:1988;1029.
52. Nagai M., Fujita M., Ikeda T., Ohmori M., Kuwabara H., Yamaoka G., Tanaka K., Kamada N., Taniwaki M., Inoue T., Irino S., Takahara J. Alterations of p53 and Rb genes in a novel human GM-CSF-dependent myeloid cell line (OHN-GM) established from therapy-related leukaemia. Br. J. Haematol. 98:1997;392.
53. Hamaguchi H., Inokuchi K., Nara N., Nagata K., Yamamoto K., Yagasaki F., Dan K. Alterations in the colorectal carcinoma gene and protein in a novel human myeloid leukemia cell line with trisomy 18 established from overt leukemia after myelodysplastic syndrome. Int. J. Hematol. 67:1998;153.
54. Nagai M., Seki S., Kitahara T., Abe T., Minato K., Watanabe S., Shimoyama M. A novel human myelomonocytoid cell line, P39/Tsugane, derived from overt leukemia following myelodysplastic syndrome. Gann. 75:1984;1100.
55. Kawaguchi R., Hosokawa Y., Komine A., Tsutsumi M., Hikiji K., Ishida-Okawara A., Suzuki K., Nakagawa T., Yamaguchi K. The monocytic cell line SKM-1 strongly expresses the myeloperoxidase gene. Leukemia. 6:1992;1296.
56. Nakagawa T., Matozaki S., Murayama T., Nishimura R., Tsutumi M., Kawaguchi R., Yokoyama Y., Hikiji H., Osobe T., Chihara K. Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome. Br. J. Haematol. 85:1993;469.
57. Nakagawa T., Saitoh S., Imoto S., Itoh M., Tsutsumi M., Hikiji K., Nakao Y., Fujita T. Loss of multiple point mutations of ras genes associated with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndromes. Br. J. Haematol. 77:1991;250.
58. Zhang L.Q., Downie P.A., Goodell W.R., McCabe N.R., LeBeau M.M., Morgan R., Sklar J., Raimondi S.C., Miley D., Goldberg A., Lu M.M., Montag A., Smith S.D. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia. Leukemia. 7:1993;1865.
59. Downie P.A., Vogelzang N.J., Moldwin R.L., Le Beau M.M., Anastasi J., Allen R.J., Myers S.E., Larson R.A., Smith S.D. Establishment of a leukemia cell line with i(12p) from a patient with a mediastinal germ cell tumor and acute lymphoblastic leukemia. Cancer. Res. 54:1994;4999.
60. Drexler H.G., Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia. 13:1999;835-842.
61. Drexler HG, Dirks WG, MacLeod RAF. False human hematopoietic cell lines: Cross-contaminations and misinterpretations. Leukemia (in press).